title: Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome.
authors.affiliation: Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden julia.asp@gu.se.
authors.forename: Julia
authors.initials: J
authors.lastname: Asp
authors.affiliation: Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden Hematology Section, Department of Medicine, NU Hospital Group, Uddevalla, Sweden.
authors.forename: Björn
authors.initials: B
authors.lastname: Andréasson
authors.affiliation: Department of Clinical Pathology and Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Ulrika
authors.initials: U
authors.lastname: Hansson
authors.affiliation: Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Carina
authors.initials: C
authors.lastname: Wasslavik
authors.affiliation: Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Johanna
authors.initials: J
authors.lastname: Abelsson
authors.affiliation: Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden Hematology Section, Department of Medicine, NU Hospital Group, Uddevalla, Sweden.
authors.forename: Peter
authors.initials: P
authors.lastname: Johansson
authors.affiliation: Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Lars
authors.initials: L
authors.lastname: Palmqvist
mesh_terms: D037282:Calreticulin / Q000235:genetics* / Q000378:metabolism; D004252:DNA Mutational Analysis; D015870:Gene Expression; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D011379:Prognosis; D053628:Receptors, Thrombopoietin / Q000235:genetics* / Q000378:metabolism; D016019:Survival Analysis; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality / Q000473:pathology
chemical_list: C576483:CALR protein, human; D037282:Calreticulin; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2
keywords: chronic myeloproliferative disorders; cytogenetics and molecular genetics; laboratory hematology